Real-Time Release Testing Surrogate Models

Uses inline spectroscopy and process signals to estimate CQAs earlier in batch disposition workflows Evidence basis: Published RTRT studies demonstrate ML surrogate models can predict dissolution and support near-real-time quality decisions; FDA PAT guidance provides a framework for model-based control when validation and lifecycle management are robust

The Problem

Real-Time Release Testing Surrogate Models

Organizations face these key challenges:

1

Uses inline spectroscopy and process signals to estimate CQAs earlier in batch disposition workflows

Impact When Solved

Uses inline spectroscopy and process signals to estimate CQAs earlier in batch disposition workflowsEvidence-backed implementation with human oversight

The Shift

Before AI~85% Manual

Human Does

  • Review batch records, lab results, and process notes to assess release readiness
  • Coordinate quality checks and follow-ups across manual spreadsheets and handoffs
  • Investigate deviations or late-emerging quality concerns before disposition
  • Decide batch disposition based on retrospective evidence and expert judgment

Automation

  • No AI-driven analysis in the legacy workflow
  • No automated prioritization of quality risk or release readiness
  • No continuous estimation of CQAs from inline process information
With AI~75% Automated

Human Does

  • Approve surrogate model use within defined release decision workflows
  • Review predicted CQA risk and decide disposition actions with supporting evidence
  • Handle exceptions, model challenges, and batches flagged for additional review

AI Handles

  • Estimate CQAs earlier using inline spectroscopy and process signals
  • Monitor batches in near real time and flag elevated quality risk or uncertainty
  • Prioritize batches for review based on predicted release readiness
  • Generate decision-support summaries for batch disposition workflows

Operating Intelligence

How Real-Time Release Testing Surrogate Models runs once it is live

AI runs the first three steps autonomously.

Humans own every decision.

The system gets smarter each cycle.

Confidence93%
ArchetypeRecommend & Decide
Shape6-step converge
Human gates1
Autonomy
67%AI controls 4 of 6 steps

Who is in control at each step

Each column marks the operating owner for that step. AI-led actions sit above the divider, human decisions and feedback loops sit below it.

Loop shapeconverge

Step 1

Assemble Context

Step 2

Analyze

Step 3

Recommend

Step 4

Human Decision

Step 5

Execute

Step 6

Feedback

AI lead

Autonomous execution

1AI
2AI
3AI
5AI
gate

Human lead

Approval, override, feedback

4Human
6 Loop
AI-led step
Human-controlled step
Feedback loop
TL;DR

AI handles assembly, analysis, and execution. The human gate sits at the decision point. Every cycle refines future recommendations.

The Loop

6 steps

1 operating angles mapped

Operational Depth

Technologies

Technologies commonly used in Real-Time Release Testing Surrogate Models implementations:

Free access to this report